Sevoflurane 1000 MG/ML Inhalation Solution — RxCUI 200243
RxNorm drug concept · Semantic clinical drug
RxCUI 200243
Semantic clinical drug · SCD
● Current RxNorm concept 15 FDA products
15 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI200243
Official nameSevoflurane 1000 MG/ML Inhalation Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assevoflurane 100 % Inhalation Solution
FDA products mapped15
Package NDCs mapped15
Reported Medicaid activity (SDUD)10,339 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sevoflurane: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Sevoflurane is a gas you breathe in through a mask to go completely under for surgery. Anesthesiologists often choose it because it works very quickly — you're typically asleep wit...
- What exactly is sevoflurane and why would my doctor use it instead of other anesthetics?
- The most common things people notice after surgery are nausea and vomiting, feeling drowsy or dizzy, and sometimes shivering. Some people — especially children — feel agitated or c...
- What side effects should I expect after waking up from sevoflurane anesthesia?
🕸️ Concept Web — How Sevoflurane 1000 MG/ML Inhalation Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sevoflurane 1000 MG/ML Inhalation Solution
RxCUI 200243 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sevoflurane
36453IN
-
Sevoflurane
-
Brand names 5
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Petrem
997615BN -
SevoFlo
1245040BN -
Sevospire
2697453BN -
Sojourn
997622BN -
Ultane
220599BN
-
Petrem
-
Dose forms 14
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sevoflurane Inhalation Solution
2108407SCDF -
Sevoflurane Inhalant Product
1159080SCDG -
Sevoflurane Inhalation Solution [Petrem]
2108409SBDF -
Sevoflurane Inhalation Solution [SevoFlo]
2108411SBDF -
Sevoflurane Inhalation Solution [Sevospire]
2697456SBDF -
Sevoflurane Inhalation Solution [Sojourn]
2108437SBDF -
Sevoflurane Inhalation Solution [Ultane]
2108439SBDF -
Petrem Inhalant Product
1178220SBDG - +6 more in this family
-
Sevoflurane Inhalation Solution
-
Clinical & branded drugs 11
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sevoflurane 1000 MG/ML
358558SCDC -
Sevoflurane 1000 MG/ML Inhalation Solution [Petrem]
997618SBD -
Sevoflurane 1000 MG/ML Inhalation Solution [SevoFlo]
1245044SBD -
Sevoflurane 1000 MG/ML Inhalation Solution [Sevospire]
2697457SBD -
Sevoflurane 1000 MG/ML Inhalation Solution [Sojourn]
997625SBD -
Sevoflurane 1000 MG/ML Inhalation Solution [Ultane]
541963SBD -
Sevoflurane 1000 MG/ML [Petrem]
997616SBDC -
Sevoflurane 1000 MG/ML [SevoFlo]
1245041SBDC - +3 more in this family
-
Sevoflurane 1000 MG/ML
Showing up to 8 concepts per family — 22 of 31 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sevoflurane 1000 MG/ML
SCDC · 358558 -
Sevoflurane Inhalation Solution
SCDF · 2108407 -
Sevoflurane Inhalant Product
SCDG · 1159080
Brand-Name Concepts
-
Sevoflurane 1000 MG/ML Inhalation Solution [Sojourn]
SBD · 997625 -
Sevoflurane 1000 MG/ML Inhalation Solution [Ultane]
SBD · 541963 -
Sevoflurane 1000 MG/ML Inhalation Solution [Petrem]
SBD · 997618 -
Sevoflurane 1000 MG/ML Inhalation Solution [SevoFlo]
SBD · 1245044 -
Sevoflurane 1000 MG/ML Inhalation Solution [Sevospire]
SBD · 2697457 -
Sevoflurane 1000 MG/ML [Petrem]
SBDC · 997616 -
Sevoflurane 1000 MG/ML [SevoFlo]
SBDC · 1245041 -
Sevoflurane 1000 MG/ML [Sevospire]
SBDC · 2697454 -
Sevoflurane 1000 MG/ML [Sojourn]
SBDC · 997623 -
Sevoflurane 1000 MG/ML [Ultane]
SBDC · 541961
📦 FDA Products & Package NDCs
15 products · 15 package NDCs
15 package NDCs map to RxCUI 200243 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00074-4456-04 | 250 mL in 1 BOTTLE, PLASTIC (0074-4456-04) | Ultane | AbbVie Inc. | 1995-06-07 |
| 00074-4456-51 | 250 mL in 1 BOTTLE, PLASTIC (0074-4456-51) | Ultane | AbbVie Inc. | 1995-06-07 |
| 00527-6123-74 | 1 BOTTLE, GLASS in 1 CARTON (0527-6123-74) / 250 mL in 1 BO... | Sevoflurane | Lannett Company, Inc. | 2023-08-18 |
| 00781-6160-86 | 6 BOTTLE, GLASS in 1 CARTON (0781-6160-86) / 250 mL in 1 BO... | Sevoflurane | Sandoz Inc. | 2017-01-25 |
| 10019-0651-64 | 6 BOTTLE in 1 CARTON (10019-651-64) / 250 mL in 1 BOTTLE | Sevoflurane | Baxter Healthcare Company | 2002-07-02 |
| 10019-0653-64 | 6 BOTTLE in 1 CARTON (10019-653-64) / 250 mL in 1 BOTTLE | SEVOFLURANE | Baxter Healthcare Corporation | 2002-07-07 |
| 10019-0655-06 | 6 BOTTLE in 1 CARTON (10019-655-06) / 250 mL in 1 BOTTLE | Sevoflurane | Baxter Healthcare Company | 2022-07-26 |
| 10019-0657-06 | 6 BOTTLE in 1 CARTON (10019-657-06) / 250 mL in 1 BOTTLE | SEVOFLURANE | Baxter Healthcare Corporation | 2022-07-26 |
| 12164-0005-25 | 250 mL in 1 BOTTLE (12164-005-25) | Sevoflurane | Halocarbon Life Sciences, LLC | 2007-11-19 |
| 42677-0308-01 | 1 BOTTLE, GLASS in 1 CARTON (42677-308-01) / 250 mL in 1 BO... | Sevoflurane | Shandong New Time Pharmaceutical Co., Ltd. | 2023-08-18 |
| 66794-0012-25 | 250 mL in 1 BOTTLE, GLASS (66794-012-25) | Sojourn | Piramal Critical Care Inc | 2010-04-13 |
| 66794-0015-25 | 250 mL in 1 BOTTLE (66794-015-25) | Sevoflurane | Piramal Critical Care Inc | 2011-07-15 |
| 66794-0022-25 | 250 mL in 1 BOTTLE (66794-022-25) | Sevoflurane | Piramal Critical Care Inc | 2020-10-01 |
| 72162-2245-02 | 250 mL in 1 BOTTLE (72162-2245-2) | Sevoflurane | Bryant Ranch Prepack | 2024-01-29 |
| 83301-0070-01 | 1 BOTTLE, GLASS in 1 CARTON (83301-0070-1) / 250 mL in 1 BO... | Sevoflurane, (Volatile for Inhalation) | Mullan Pharmaceutical Inc. | 2026-02-16 |
Observed labelers:
Piramal Critical Care Inc (3) ·
AbbVie Inc. (2) ·
Baxter Healthcare Company (2) ·
Baxter Healthcare Corporation (2) ·
Bryant Ranch Prepack (1) ·
Halocarbon Life Sciences, LLC (1)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.